SEHK:2269Life Sciences
WuXi Biologics (Cayman) (SEHK:2269) Shares Climbed, So What Is Driving Attention Now?
WuXi Biologics (Cayman) half year earnings in focus
WuXi Biologics (Cayman) (SEHK:2269) reported half year 2026 earnings, noting higher sales, net income and earnings per share compared with the same period in 2025.
See our latest analysis for WuXi Biologics (Cayman).
Alongside these half year results, WuXi Biologics (Cayman) has seen strong recent momentum, with a 30 day share price return of 33.5% and a 90 day share price return of 54.99%, while the 1 year total shareholder return is...